The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors

European Journal of Pharmacology

Volumn 296, Issue 2, 1996, Pages 199-207

  Hatzoglou, Anastassia ^a,c   Bakogeorgou, Efstathia ^a   Castanas, Elias ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b INSERM   (France)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Breast cancer cell (T47D); Cell proliferation; Opioid; Opioid receptor; Opioid receptor subtype

Indexed keywords

DELTA OPIATE RECEPTOR; DIPRENORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ETHYLKETAZOCINE; ETORPHINE; KAPPA 2 OPIATE RECEPTOR; KAPPA 3 OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA1 OPIATE RECEPTOR; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHICEPTIN; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030051996     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00703-2     Document Type: Article

References (30)

1. Attali, B., C. Guarderes, H. Mazarguil, Y. Audigier and J. Cros, 1982, Evidence for multiple κ binding sites by use of opioid peptides in the guinea pig lumbo-sacral spinal cord, Neuropeptides 3, 53.
2. Aylsworth, C.F., C.A. Hudson and J. Meites, 1979, Opiate antagonists can inhibit mammary tumor growth in rats, Proc. Soc. Exp. Biol. Med. 161, 18.
3. Bostwick, D.G., W.E. Null, D. Holmes, E. Weber, J.D. Barchas and K.G. Bensch, 1987, Expression of opioid peptides in tumors, New Engl. J. Med. 317, 1439.
4. Castanas, E., P. Giraud, Y. Audigier, R. Drissi, F. Boudouresque, B. Conte-Devolx and C. Oliver, 1984, Adrenal medullary opiate receptors: pharmacological characterization in bovine adrelal medulla and a human pheochromocytoma, Mol. Pharmacol. 25, 38.
5. Castanas, E., N. Bourhim, P. Giraud, F. Boudouresque, P. Cantau and C. Oliver, 1985a, Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites, J. Neurochem. 45, 677.
6. Castanas, E., N. Bourhim, P. Giraud, F. Boudouresque, P. Cantau and C. Oliver, 1985b, Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites, J. Neurochem. 45, 688.
7. Fowler, C. J. and G. L. Fraser, 1994, μ-, δ-, κ-Opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments, Neurochem. Int. 24, 401.
8. Hatzoglou, A., S. Romain, H. Dalapascha and E. Castanas, 1994, Acidification reveals a greater number of Epidermal Growth Factor Receptors in human membrane preparations, Clin. Chim. Acta 227, 97.
9. Hatzoglou, A., A. Gravanis, E. Zoumakis, A. Margioris and E. Castanas, 1995, Identification and characterization of opioid binding sites present in the Ishikawa human endometrial adenocarcinoma cell line, J. Clin. Endocrinol. Metab. 80, 418.
10. Ilyinsky, O.B., M.V. Kozlova, E.S. Kondrikova, V.U. Kalentchuk, M.I. Titov and Z.D. Bespalova, 1987, Effects of opioid peptides and naloxone on nervous tissue in culture, Neuroscience 22, 719.
11. Kiefer, B.L., K. Befort, C. Gaveriaux-Ruff and C.G. Hirth, 1992, The δ-opioid receptor: Isolation of a cDNA by expression-cloning and pharmacological characterization, Proc. Natl. Acad. Sci. USA 89, 12048.
12. Kikuchi, Y., T. Kita, M. Miyauchi, I. Kizawa, K. Oomori and K. Kato, 1987, Effects of naloxone on human ovarian cancer cell growth in vitro and in vivo, Jpn. J. Cancer Res. 78, 519.
13. Kita, T., Y. Kikushi, K. Ooomori and I. Nagata, 1992, Effects of opioid peptides on the tumoricidal activity of spleen cells from nude mice with or without tumors, Cancer Detect. Prev. 16, 211.
14. Maneckjee, R. and J.D. Minna, 1990, Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines, Proc. Natl. Acad. Sci. USA 87, 3294.
15. Maneckjee, R., R. Biswas and B.K. Vonderhaar, 1990, Binding of opioids to human MCF-7 breast cancer cells, and their effects on growth, Cancer Res. 50, 2234.
16. Munson, P.J. and D. Rodbard, 1980, LIGAND: a versatile computerized approach to characterization of ligand-binding systems, Anal. Biochem. 107, 220.
17. Murgo, A.J., 1989, Modulation of murine melanoma growth by naloxone, Cancer Lett. 44, 137.
18. Scholar, E.M., L. Violi and T.D. Hexum, 1987, The antimetastatic effect of enkephalin-like peptides, Cancer Lett. 35, 133.
19. Scopsi, L., E. Balslev, N. Brunner, H. Skovgaart-Poulsen, J. Andersen, F. Rank and L.-I. Larson, 1989, Immunoreactive opioid peptides in human breast cancer, Am. J. Pathol. 134, 473.
20. Tsunashima, K., 1982, Anticancer effect of naloxone, Proc. Jpn. Cancer Assoc. 425.
21. Von Hoff, D.D. and B. Forseth, 1982, Modulation of growth of human and murine tumors by human β-endorphin, Proc. Am. Assoc. Cancer Res. March, Abstract 932.
22. Xie, G.-X., A. Miyagima and A. Goldstein, 1992, Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands, Proc. Natl. Acad. Sci. USA 89, 4124.
23. Yusuda, K., K. Raynor, H. Kong, C.D. Breder, J. Takeda, T. Resine and G.I. Bell, 1993, Clonning and functionnal comparison of κ and δ opioid receptors from mouse brain, Proc. Natl. Acad. Sci. USA 90, 6736.
24. Zagon, I.S. and P.J. McLaughlin, 1981a, Naloxone prolongs the survival time of mice treated with neuroblastoma, Life Sci. 28, 1095.
25. Zagon, I.S. and P.J. McLaughlin, 1981b, Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma, Brain Res. Bull. 7, 25.
26. Zagon, I.S. and P.J. McLaughlin, 1983, Naltrexone modulates tumor response in mice with neuroblastoma, Science (Wash. DC) 221, 671.
27. Zagon, I.S. and P.J. McLaughlin, 1984, Duration of opiate receptor blockade determines tumorigenic responce in mice with neuroblastoma: A role for endogenous opioid systems in cancer, Life Sci. 35, 409.
28. Zagon, I.S. and P.J. McLaughlin, 1989, Endogenous opioid systems regulate growth of neural tumor cells in culture, Brain Res. 490, 14.
29. Zagon, I.S., P.J. McLaughlin, A.E. Takemori and P.S. Portoghese, 1985, β-Fulnatrexamine (β-FNA) and neural tumor responce in mice, Eur. J. Pharmacol. 116, 165.
30. Zagon, I.S., P.J. McLaughlin, S.R. Goodman and R.E. Rhodes, 1987, Opioid receptors and endogenous opioids in diverse human and animal cancers, J. Natl. Cancer Inst. 79, 1059.